°øÁö : µµÄìÁõ±Ç°Å·¡¼Ò JASDAQ ½ºÅÄ´Ùµå ½ÃÀå ½Å±Ô »óÀå °ü·Ã ¾È³»

Global Information
ȸ»ç¼Ò°³ | ¹®ÀÇ | ºñ±³¸®½ºÆ®

¹Ì±¹ÀÇ ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå

Peripheral Vascular Devices | Medtech 360 | Market Insights | United States

¸®¼­Ä¡»ç Decision Resources Group - Medtech
¹ßÇàÀÏ 2019³â 12¿ù »óǰ ÄÚµå 142027
ÆäÀÌÁö Á¤º¸ ¿µ¹®
°¡°Ý
ÀÚ¼¼ÇÑ ³»¿ëÀº ¹®Àǹٶø´Ï´Ù.

¹Ì±¹ÀÇ ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå Peripheral Vascular Devices | Medtech 360 | Market Insights | United States
¹ßÇàÀÏ : 2019³â 12¿ù ÆäÀÌÁö Á¤º¸ : ¿µ¹®

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹®¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀϺ»ÀÇ ¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀº ¸»Ãʵ¿¸ÆÁúȯ(PAD) ȯÀÚ ¼ö°¡ ¸¹¾Æ ¾ÕÀ¸·Îµµ Áõ°¡°¡ ¿¹»óµÇ´Â µ¥´Ù »õ·Î¿î Â÷¼¼´ë Á¦Ç°ÀÌ µîÀåÇϰí ÀÖ´Ù´Â Á¡¿¡¼­ ¿¹Ãø±â°£ Áß ¾î´À Á¤µµÀÇ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. ±×·¯³ª À¯·´°ú ¹Ì±¹ ½ÃÀå¿¡ ºñÇØ ½ÂÀÎµÈ Á¦Ç°ÀÌ ÀûÀº Á¡ÀÌ ¸¶À̳ʽº ¿äÀÎÀ̶ó°í ÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö±Ý±îÁö´Â ¾ð¾îÀÇ À庮, ±ÔÁ¦ ´ç±¹ÀÇ ¾ö°ÝÇÑ ±âÁØ, º¹ÀâÇÑ µî·Ï °úÁ¤ÀÌ ÀϺ» ½ÃÀå ÁøÃâÀÇ Å« À庮ÀÌ µÇ¾î ´Ù±¹Àû ±â¾÷ÀÇ ±Û·Î¹ú Àü·«¿¡¼­ ÀϺ»Àº À¯·´°ú ¹Ì±¹ ½ÃÀå¿¡ ºñÇØ ¿ì¼± ¼øÀ§°¡ ³·Àº ±¹°¡·Î °£ÁֵǴ °á°ú¸¦ °¡Á®¿ÔÀ¸¸ç, ½ÅÁ¦Ç°ÀÇ ÀϺ» ÁøÃâÀº ´õ¿í Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù.

±×·¯³ª ½ÃÀåÀº ¾à¹°¹æÃâdz¼±(DCB), ¾à¹°¿ëÃ⽺ÅÙÆ®(DES), ¸¸¼º¿ÏÀüÆó¼â(CTO) º´º¯ Åë°ú °¡À̵å¿ÍÀÌ¾î µî °í°¡ ±â±âÀÇ Ã¤¿ë¿¡ ÁöÁöµÉ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±âÀÇ »ç¿ëÀ» µÞ¹ÞħÇÏ´Â »õ·Î¿î ÀÓ»ó µ¥ÀÌÅͰ¡ ¹ßÇ¥µÇ¸é¼­ ä¿ë ºñÀ²ÀÌ ³ô¾ÆÁú °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î Lutonix BTK ½ÃÇè¿¡¼­´Â ½½Çϵ¿¸Æ¿¡¼­ DCB »ç¿ëÀÇ À¯¿ë¼ºÀ» ³ªÅ¸³» DCBÀÇ »ç¿ë Áõ°¡°¡ ¿¹»óµË´Ï´Ù.

ÆÄŬ¸®Å¹¼¿À» µµÆ÷ÇÑ DCB ¹× DESÀÇ »ç¿ëÀ» µÑ·¯½Î°í, 2018³âÀÇ ¸ÞŸ ºÐ¼® °á°ú¿¡ µû¶ó (ÀÌÈÄ Katsanos study·Î Ç¥±â, Katsanos K 2018) ¿ì·ÁÀÇ ¸ñ¼Ò¸®°¡ ³ª¿À°í ÀÖÀ¸¸ç, ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ¹× PTA dz¼± Ä«Å×ÅÍ ½ÃÀå¿¡ ´Ù¼Ò ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ÃÊ·¡ÇÏÁö¸¸, ÀϺ»ÀÇ ¿µÇâÀº À¯·´°ú ¹Ì±¹ ½ÃÀ常ŭ ½É°¢ÇÏÁö ¾Ê´Ù°í »ý°¢µË´Ï´Ù.

ÀϺ»ÀÇ ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå ¼ºÀåÀº Àα¸ °í·ÉÈ­ µî Àα¸Åë°èÇÐÀû ¿äÀο¡ ÈûÀÔÀº °ÍÀÔ´Ï´Ù. °í·ÉÈ­¿¡ µû¶ó Ä¡·á¸¦ ÇÊ¿ä·Î ÇÏ´Â ¸»ÃÊÇ÷°ü Àå¾Ö ȯÀÚ ¼öÀÇ Áõ°¡°¡ ¿¹»óµË´Ï´Ù.

2019³â ½ÃÀåÀÇ ¼±µÎ¿¡ ¼± °ÍÀº Boston ScientificÀ̾ú½À´Ï´Ù. Boston ScientificÀº PTA dz¼± Ä«Å×ÅÍ ¹× »öÀü¹æÁö ±â±â(EPD)·Î ½ÃÀå 1À§ÀÇ Æ÷Æ®Æú¸®¿À¸¦ º¸À¯Çϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ Á¦Ç°±º¿¡¼­ ±àÁ¤ÀûÀÎ ÀÓ»ó µ¥ÀÌÅ͸¦ º¸¿© ÀÇ»ç »çÀÌ¿¡¼­ ÀÎÁöµµ°¡ ³ôÀº °ÍÀÌ ½Â¸®ÀÇ ¿äÀÎÀÔ´Ï´Ù.

¶ÇÇÑ Boston ScientificÀº 2018³â¿¡ ¹ß¸ÅµÈ Eluvia DES¿¡ ÀÇÇØ¼­µµ ¿ìÀ§¿¡ ¼³ °ÍÀÔ´Ï´Ù. ÀÌ Á¦Ç°Àº ±âÁ¸ DES ½ÃÀåÀ» ¾ÐµµÇؿԴø Cook MedicalÀÇ Zilver PTX DESÀÇ °­·ÂÇÑ ¶óÀ̹úÀÌ µÉ Àü¸ÁÀÔ´Ï´Ù. Boston Scientific¿¡ ´ëÇÑ ³ôÀº Æò°¡¿Í ¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀ» ¸Á¶óÇÏ´Â ±¤¹üÀ§ÇÑ Æ÷Æ®Æú¸®¿À¸¦ ÅëÇØ ÀÌ »õ·Î¿î ÇÁ¸®¹Ì¾ö Á¦Ç°ÀÇ °ßÁ¶ÇÑ ¸ÅÃâÀÌ Àü¸ÁµÇ¸ç, ¸»ÃÊÇ÷°ü ±â±â ¿µ¿ª¿¡¼­ Boston ScientificÀÇ ¿ì¼¼°¡ ´õ¿í È®½ÇÇØÁú °ÍÀÔ´Ï´Ù.

2019³â ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå Àüü 2À§´Â Cardinal Health¿´½À´Ï´Ù. Cardinal Health´Â ÀÌ ½ÃÀå¿¡¼­ °¡Àå Å« ºÎ¹®ÀÎ ¸»ÃÊÇ÷°ü ½ºÅÙÆ®¿¡¼­ ¼±µÎÀ̸ç, EPD ¹× PTA dz¼± Ä«Å×ÅÍ ºÎ¹®¿¡¼­µµ »ó´çÇÑ Á¡À¯À²À» Â÷ÁöÇØ ¿ìÀ§¿¡ ÀÖ½À´Ï´Ù.

¾Õ¼­ ¾ð±ÞÇßµíÀÌ ÀϺ»ÀÇ ¸»ÃÊÇ÷°ü ½ºÅÙÆ® ½ÃÀå¿¡¼­ ÆÄŬ¸®Å¹¼¿ µµÆ÷ dz¼±°ú ½ºÅÙÆ®¿¡ °üÇÑ Katsanos studyÀÇ °á°ú·Î ¾î´À Á¤µµÀÇ ¸¶À̳ʽº ¿µÇâÀÌ ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ±â±âÀÇ ¾ÈÀü¼º¿¡ °üÇÑ ÀÇ»ç¿Í ȯÀÚÀÇ ¿ì·Á·Î ä¿ëÀº ´Ù¼Ò ħüµÇ°í, DCB ¹× DES Á¦Ç°À» Á¦°øÇÏ´Â ±â¾÷¿¡¼­´Â ¼öÀÍ °¡´É¼ºÀÌ Á¦ÇÑµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀüüÀûÀÎ ½ÃÀå Á¡À¯À²¿¡µµ ¿µÇâÀÌ ¹ÌÄ¥ °ÍÀÔ´Ï´Ù. ±×·¯³ª ÀÎÅͺ信 Çù·ÂÇÑ ÀÇ»çµéÀº Katsanos study ½ÃÇèÀÇ ¿µÇâÀº ÀϺ»¿¡¼­´Â À¯·´°ú ¹Ì±¹ÀÇ ¿µÇ⸸ŭ Å©Áö ¾Ê°í, °¢ ±â¾÷ÀÇ Á¡À¯À²¿¡ ±×´ÙÁö Å« ¸¶À̳ʽº ¿µÇâÀº ¹ÌÄ¡Áö ¾ÊÀ» °ÍÀ̶ó´Â °ßÇØ¸¦ º¸¿´½À´Ï´Ù.

º» ½ÃÀå¿¡¼­´Â °¢ ±â¾÷ ¸ðµÎ DCB ¶Ç´Â õ´ëÅ𵿸Æ(SFA)°ú ±ÙÀ§½½¿Íµ¿¸Æ º´º¯ Ä¡·á¸¦ À§ÇÑ DES µî ´õ ³ôÀº ¼öÀÍ °¡´É¼ºÀ» °¡Á®¿Ã ¼ö ÀÖ´Â Á¦Ç° °³¹ß¿¡ ÃÊÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î Boston ScientificÀº 2018³â¿¡ ÀϺ»¿¡¼­ Eluvia DES¸¦ Ãâ½ÃÇßÁö¸¸ Ranger DCB¸¦ Æò°¡ÇÏ´Â ±¹Á¦ÀûÀÎ ÀÓ»ó½ÃÇèµµ ½Ç½Ã ÁßÀ̸ç, Ãʱ⠼ºÀûÀº ±àÁ¤ÀûÀÔ´Ï´Ù. Ranger°¡ ½ÃÆÇµÇ¸é ¸»ÃÊÇ÷°ü ½ºÅÙÆ®¿Í PTA dz¼± Ä«Å×ÅÍ ½ÃÀå ¸ðµÎ¿¡¼­ °æÀï °¡´ÉÇϸç, Boston ScientificÀÇ ¼öÀÍ °¡´É¼ºÀº »ó´çÈ÷ ³ô¾ÆÁú °ÍÀÔ´Ï´Ù.

¹Ì±¹ÀÇ ¸»ÃÊÇ÷°ü ±â±â(Peripheral Vascular Devices) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, Á¾ÇÕÀûÀÎ µ¥ÀÌÅÍ »Ó¸¸ ¾Æ´Ï¶ó ½ÃÀå ÇöȲ, ÇâÈÄ µ¿Çâ, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ µî¿¡ ´ëÇÑ Ã¼°èÀûÀÎ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

°³¿ä

¾÷µ¥ÀÌÆ® ³»¿ª

¸»ÃÊÇ÷°ü ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ¿¹Ãø µ¥ÀÌÅÍ
    • ¸»ÃÊÇ÷°ü ÁßÀç ½Ã¼ú
  • °æÀï °³¿ä
  • ½ÃÀå Á¡À¯À²
  • °æÀï¿äÀΰú Àü·«
    • »óȯ
    • Á¦Ç°ÀÇ °³¼±°ú Çõ½Å
    • ÀÓ»ó µ¥ÀÌÅÍ
    • ¼±ÇàÀÚ ÀÌÀÍ
    • Á¦Ç° Æ÷Æ®Æú¸®¿À °ü¸®
    • »õ·Î¿î ±â¼ú
    • M&A, Á¦ÈÞ
    • ½ÃÀå¿¡ ´ëÇÑ ¾îÇÊ
    • ±ÔÁ¦ ȯ°æ
  • ½ÃÀå °³¹ß

¸»ÃÊÇ÷°ü ½ºÅÙÆ® ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ¿¹Ãø µ¥ÀÌÅÍ
    • Á¦Ç° Á¾·ùº°
  • °æÀï °³¿ä
  • ½ÃÀå Á¡À¯À²
  • °æÀï¿äÀΰú Àü·«
    • Á¦Ç°ÀÇ °³¼±°ú Çõ½Å
    • ±â¾÷ ÀμöÇÕº´(M&A), »ç¾÷ Á¦ÈÞ

PTA dz¼± Ä«Å×ÅÍ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ¿¹Ãø µ¥ÀÌÅÍ
  • °æÀï °³¿ä
  • ½ÃÀå Á¡À¯À²
  • °æÀï¿äÀΰú Àü·«
    • Á¦Ç°ÀÇ °³¼±°ú Çõ½Å
    • Á¦Ç° Æ÷Æ®Æú¸®¿À °ü¸®
    • »õ·Î¿î ±â¼ú
    • ½ÃÀå¿¡ ´ëÇÑ ¾îÇÊ

Á×Á¾Á¦°Å¼ú ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ¿¹Ãø µ¥ÀÌÅÍ
  • °æÀï °³¿ä
  • ½ÃÀå Á¡À¯À²
  • °æÀï¿äÀΰú Àü·«
    • ¼±ÇàÀÚ ÀÌÀÍ
    • ¼­ºñ½º ÁöÁ¡

¸¸¼º¿ÏÀüÆó¼â Ⱦ´Ü¿ë ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ¿¹Ãø µ¥ÀÌÅÍ
  • °æÀï °³¿ä
  • ½ÃÀå Á¡À¯À²
  • °æÀï¿äÀΰú Àü·«
    • Á¦Ç°ÀÇ °³¼±°ú Çõ½Å
    • ½ÃÀå¿¡ ´ëÇÑ ¾îÇÊ

»öÀüº¸È£ ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ¿¹Ãø µ¥ÀÌÅÍ
  • °æÀï °³¿ä
  • ½ÃÀå Á¡À¯À²
  • °æÀï¿äÀΰú Àü·«

¿Ü°ú¿ë ±×·¡ÇÁÆ® ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ¿¹Ãø µ¥ÀÌÅÍ
  • °æÀï °³¿ä
  • ½ÃÀå Á¡À¯À²
  • °æÀï¿äÀΰú Àü·«

¸»ÃÊÇ÷°ü¿ë ºÎ¼Ó ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ¿¹Ãø µ¥ÀÌÅÍ
  • °æÀï °³¿ä
  • ½ÃÀå Á¡À¯À²
  • °æÀï¿äÀΰú Àü·«

ºÎ·Ï

KSM 20.01.23

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for significant expansion through 2028.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in the US across a 10-year period.

The publication of the Katsanos study in late 2018 and its fallout had a significant impact on the DCB market in 2019

  • What effect did data highlighting safety concerns with paclitaxel-coated devices have on the DCB market?
  • To what degree was DCBs adoption in the US curtailed over the forecast period?
  • How many competitors will enter the DCB market, and who will gain the most market share?
  • How were other PTA balloon catheter markets effected by turmoil in the DCB market?
  • How will DCB uptake affect other PV devices such as stents, and atherectomy devices?
  • Which new indications will drive growth in the DCB market?

A focus on noninvasive lower-extremity revascularization will contribute to increasing endovascular procedure volumes.

  • How will the adoption of and familiarity with CTO crossing devices affect the fem-pop and infrapop device markets?
  • How has CMS reimbursement affected the use of atherectomy by site of service?
  • What impact will the rising role of office-based procedures have on the lower-extremity market?

Table of Contents

United States

Abstract

Executive Summary

  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • End-User Insights
  • Procedures Covered
  • Products Covered

Key Report Updates

Peripheral Vascular Device Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Endovascular Interventional Procedures
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Reimbursement
    • Product Improvements and Innovations
    • Clinical Data
    • First-Mover Advantage
    • Product Portfolio Management
    • Emerging Technologies
    • Mergers, Acquisitions, and Partnerships
    • Sites of Service
    • Market Appeal
    • Regulatory Environment
  • Market Developments

Peripheral Vascular Stent Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • By Product Type
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Reimbursement
    • Emerging Technologies

PTA Balloon Catheter Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Product Improvements and Innovations
    • Product Portfolio Management
    • Emerging Technologies
    • Market Appeal

Atherectomy Device Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • First-Mover Advantage
    • Sites of Service

Embolic Protection Device Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Chronic Total Occlusion Crossing Device Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Product Improvements and Innovations

Peripheral Vascular Accessory Device Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Thrombectomy and Thrombolysis Device Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Surgical Graft Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Appendix

  • Abbreviations
  • Bibliography
Back to Top
ÀüÈ­ ¹®ÀÇ
F A Q